For: | Wang CR, Tsai HW. Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. World J Diabetes 2021; 12(3): 238-260 [PMID: 33758645 DOI: 10.4239/wjd.v12.i3.238] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i3/238.htm |
Number | Citing Articles |
1 |
Zeinab Vafaeipour, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh. Effect of saffron, black seed, and their main constituents on inflammatory cytokine response (mainly TNF-α) and oxidative stress status: an aspect on pharmacological insights. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(10): 2241 doi: 10.1007/s00210-023-02501-w
|
2 |
Song-Chou Hsieh, Ping-Han Tsai, Chang-Fu Kuo, Tien-Tsai Cheng, Ning-Sheng Lai, Jing-Chi Lin, Liang-Hung Lin, Chang-Youh Tsai. Health-related quality of life improvement by adalimumab therapy in patients with rheumatoid arthritis in Taiwan: A nationwide prospective study. Journal of the Chinese Medical Association 2023; 86(4): 366 doi: 10.1097/JCMA.0000000000000889
|
3 |
Yu Zhou, Wenhuo Xie, Linyao Wang, Xinyan Zhu, Jianbin Li, Libin Liu, Shuaijun Zhu, Lijing Wang. Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis. Drug Safety 2022; 45(9): 951 doi: 10.1007/s40264-022-01210-2
|
4 |
Di Wu, Yehao Luo, Tong Li, Xinyi Zhao, Ting Lv, Gang Fang, Peiqi Ou, Hongyi Li, Xiaofan Luo, An Huang, Yuzhou Pang. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1051082
|
5 |
Jun Shu, Nan Li, Wenshi Wei, Li Zhang. Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetes. Gene 2022; 810: 146070 doi: 10.1016/j.gene.2021.146070
|
6 |
Fabrizio Cantini, Delia Goletti, Maurizio Benucci, Rosario Foti, Arianna Damiani, Laura Niccoli. Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements. Expert Opinion on Drug Safety 2022; 21(5): 613 doi: 10.1080/14740338.2022.2020247
|
7 |
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
|
8 |
Jing Li, Yazhuo Chen, Qingyun Liu, Zhufang Tian, Yan Zhang. Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus. Clinical and Experimental Medicine 2022; 23(2): 287 doi: 10.1007/s10238-022-00816-1
|
9 |
Emmanuelle Rochette, Oussama Saidi, Étienne Merlin, Pascale Duché. Physical activity as a promising alternative for young people with juvenile idiopathic arthritis: Towards an evidence-based prescription. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1119930
|
10 |
Qian Zhang, Du Jin, Xiaoyue Mou, Hengli Ye. PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis. Journal of Clinical Laboratory Analysis 2022; 36(3) doi: 10.1002/jcla.24267
|
11 |
Chrong-Reen Wang, Hung-Wen Tsai. Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study. World Journal of Diabetes 2022; 13(6): 454-465 doi: 10.4239/wjd.v13.i6.454
|
12 |
Yuliya Fedorchenko, Khaiyom Mahmudov, Zhumabek Abenov, Olena Zimba, Marlen Yessirkepov. Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations. Rheumatology International 2023; 43(12): 2167 doi: 10.1007/s00296-023-05453-9
|